PhD in HIV-1 Reservoir Diagnostics for Biomedical Laboratory Science Graduates

PhD in HIV-1 Reservoir Diagnostics for Biomedical Laboratory Science Graduates

Quick Decision

What can a clinical measurement establish about an HIV reservoir when sampled material varies and patient histories may be incomplete? This KI doctorate connects laboratory diagnostics, hospital cohorts and quantitative interpretation. BioLabX adds a distinct purpose: research and future-educator training for Biomedical Laboratory Science graduates. The opportunity is attractive for a recognised professional graduate who can connect laboratory quality with a clear research question. Professional-degree eligibility is the first decision to resolve, followed by the current salary, supervision and funded study plan. KI official doctoral vacancy STÖD 2-3548/2026 Uppsala coordinator BioLabX grant record There is one 100% salaried position, closing 13 November 2026. The official vacancy does not specify the closing hour, timezone, start date or salary amount. Apply through the vacancy-specific Varbi process; the application deadline alone does not establish that applications are still being accepted; confirm status at the official vacancy before applying. Four full-time years describes doctoral education, while individual appointments are shorter. A generic biology MSc does not automatically satisfy the explicitly restricted Biomedical Laboratory Science degree or equivalent qualification. Clarify that distinction through the recruitment contact and submit complete evidence in Varbi; do not wait for an unofficial email assessment of academic documents. KI official doctoral vacancy STÖD 2-3548/2026 KI doctoral entry requirements and foreign academic documents KI doctoral employment

Research Problem and Doctoral Work

What needs to be understood

Suppressed circulating virus does not by itself answer how residual viral material should be characterised or how a clinical measurement should be interpreted. This is a measurement and evidence problem as well as a biological one. A signal in a sampled compartment is not automatically a measure of the whole body, and a molecular signal is not interchangeable with a functional clinical endpoint. The project's clinical-cohort connections make these distinctions relevant to actual diagnostic interpretation. The vacancy describes research development; it does not promise an established clinical test or a cure. KI official doctoral vacancy STÖD 2-3548/2026 Linking gut microbiome to HIV-1 reservoir size in people living with HIV

What the researcher would do

The clinical project concerns HIV-1 proviral DNA in samples from people living with HIV, linked to an ongoing Karolinska University Hospital cohort. The advertised work has distinct responsibilities:

Responsibility	What it can establish, and its limit
Develop and improve the analytical workflow for clinical proviral-DNA information	Whether measurements and their interpretation are comparable; this is research development, not an already validated clinical test
Characterise genetic diversity, viral subtype, resistance-related variation, hypermutation and other sequence features	The composition of observed molecular information; no sequence feature alone establishes a functional reservoir or a patient's clinical outcome
Use bioinformatics and phylogenetic analysis	Organise variation and relatedness in the available data; relatedness is different from a demonstrated biological mechanism
Contribute to biobanking of all incoming samples	Maintain the sample-to-clinical-information connection within approved stewardship; access to every dataset is not automatically granted
Later characterise selected participants' immune and reservoir-function information	A different evidence layer from sequence description; the vacancy names flow cytometry/FACS and ELIspot categories, without assigning a public experimental protocol

The work combines molecular virology, immunology and computation. Molecular laboratory work, sequencing/NGS, R or Python, Linux and immunological experience are preferred backgrounds, rather than a requirement to master every method before applying. All incoming samples are mentioned for biobanking, whereas later immune characterisation concerns selected participants. Recruitment does not state the laboratory/computation split, accessible cohort size, data permissions, validation milestones or daily analytical support. These determine feasibility and should enter the individual plan. Exact KI vacancy

Possible research angles, not assigned tasks, are measurement comparability across clinical datasets, the consequences of missing treatment histories, and transparent reporting of uncertainty when sample availability is selective. A useful doctorate would explain what an analysis can support and what remains unresolved. Reproducible documentation, appropriate data access and well-defined outcomes are plausible transferable contributions; the public information does not justify promising a particular publication count or result. These suggestions concern clinical evidence quality, not an experimental protocol. 2026 EuResist clinical outcome cohort Natural occurrence of drug resistance mutations to the HIV-1 capsid inhibitor lenacapavir Linking gut microbiome to HIV-1 reservoir size in people living with HIV

School, Programme and Field Context

KI is the university employer and doctoral home. The research host is the Department of Medicine, Huddinge (MedH), within the Centre for Infectious Medicine and the ANA Futura environment at Flemingsberg. The Karolinska University Laboratory and hospital provide clinical collaboration, including the national reference-laboratory setting described in the advert. They are distinct institutional roles; hospital participation does not establish hospital degree-awarding authority. KI describes its doctoral main area as medical science. KI official doctoral vacancy STÖD 2-3548/2026 KI doctoral entry requirements and foreign academic documents KI Department of Medicine Huddinge KI's institutional ranking page reports ARWU 2026 overall 41 and QS 2026 Medicine subject 10. These support a substantial medical-research environment, with different ranking scopes; they do not measure this team's supervision or establish admission probability. KI's specialised profile is outside the QS overall multi-faculty ranking. The more relevant disciplinary evidence here is the clinical setting, department-level doctoral support and directly related publications. MedH reports approximately 180 doctoral students. KI ranking with overall and subject scope MedH doctoral education BioLabX is a seven-university national initiative linking professional laboratory science with research and educational capacity. Uppsala coordinates the research environment; that does not make Uppsala this position's degree home or imply a joint degree. The vacancy requires two common courses plus seminars, workshops and annual retreats alongside KI compulsory doctoral courses. Pedagogy, leadership and supervision are part of the network's purpose. KI's institutional news specifically identifies the Maarten project among its BioLabX awards. Network/project funding is not a personal cash allowance. KI official doctoral vacancy STÖD 2-3548/2026 KI four BioLabX doctoral projects Uppsala coordinator BioLabX grant record The education corresponds to four net full-time years. KI requires an individual study plan (ISP), submitted within one month and established within three months, with annual follow-up. The current linked Medical Science syllabus requires at least 30 credits in courses and other educational activities for the PhD, and states that at least 10 credits should be obtained by the half-time review. The formal supervisor team, individual course selection/credit transfer and registration/start sequence need confirmation. This total is not 30 credits plus the activities counted within it. Current syllabus page Linked Medical Science syllabus Employment and doctoral admission remain separate decisions. A structured ISP should make the research, BioLabX obligations and any departmental duties achievable within funded time. KI doctoral employment KI individual study plan MedH doctoral education

Supervisor and Lab Assessment

Team and resources

Maarten van de Klundert's official profile identifies him as a Research Specialist and team leader, with a 2016 Amsterdam PhD and work connecting molecular epidemiology with InfCareHIV, EuResist and EuCare. He is situated within Anders Sönnerborg's research environment. The group describes three interacting clinical, translational and experimental teams. This is relevant access to complementary expertise, but does not establish which senior researcher provides routine supervision or how much time each contributes. Maarten van de Klundert official profile Sönnerborg group: clinical, translational and experimental teams The vacancy places work at ANA Futura and in close clinical-laboratory collaboration. MedH lists the Centre for Bioinformatics and Biostatistics as a coordination resource at Flemingsberg. Its current facilities page also notes that several former departmental facilities moved into the central RIKI organisation from 1 October 2026. A university facility listing is not a reserved instrument, funded service budget or assigned analyst. Confirm project-specific access, training and support. KI official doctoral vacancy STÖD 2-3548/2026 MedH facilities and organisational change

Three recent publications: contribution and limits

1. Parczewski and colleagues, AIDS, 2026. Sönnerborg and van de Klundert coauthor a real-world treatment-outcome comparison involving 261 and 1,042 participants. Some follow-up events differed, while final suppression was not clearly different. Its relevance is handling clinical records and endpoint interpretation. The existing assessment uses the structured PubMed abstract rather than the full methods; it cannot establish causal effects or validate a reservoir diagnostic. 2026 EuResist clinical outcome cohort 2. Weibull Wärnberg and colleagues, HIV Medicine, 2025. The four-author paper analyses 21,646 public molecular records from individuals without prior exposure to the studied medicine. Its contribution here is understanding baseline variation and dataset provenance, rather than designing biological interventions. The authors note selection bias because this information is not routinely generated for every patient; its presence in a public database does not establish population prevalence or clinical effect. Some variants' clinical significance remains unresolved. The contribution statement assigns conceptualisation to Sönnerborg and van de Klundert, and analysis to van de Klundert and Ceña-Diez. This supports access to clinical-data interpretation expertise, not validation of a reservoir test. The existing discussion draws on the original hospital PDF’s abstract/design, limitation/conclusion and author-contribution selections, not a complete methods review. Original paper 3. Kieri and colleagues, Gut Pathogens, 2026. This wider-group paper includes Sönnerborg, not van de Klundert. Of 90 participants in a parent clinical trial, 39 provided the relevant baseline samples and 9 were excluded after recent antibiotic exposure, leaving 30 for this cross-sectional analysis. Group-level microbiome evenness differed, but continuous linear analysis did not find a significant association with individual intact-reservoir size, and a previously reported microbiome-ratio finding was not reproduced. The result is therefore more qualified than a uniform microbiome–reservoir relationship. Basic dietary information, blood-only measurement, sample selection and small size constrain interpretation. The parent trial's prospective label does not turn this baseline substudy into a longitudinal causal result. It helps frame measurement and cohort questions; it does not add a microbiome-intervention task to this vacancy. Its interpretation is limited to the abstract, cohort/design and discussion/limitations, rather than a complete experimental-method audit. Original paper Together, the papers support an active clinical-data and measurement environment. They do not demonstrate a validated cure strategy, guaranteed experimental success or project-specific sample access. Public information did not establish laboratory graduation rates, individual mentoring quality or alumni placement statistics.

Funding, Application and Living Cost

Employment and the salary-date issue

The vacancy offers doctoral employment following KI's salary ladder, free access to its modern gym and reimbursement for medical care under applicable rules. KI permits an initial appointment of at most one year, with renewals at most two years at a time; one-year appointments are recommended. Planned departmental duties up to 20% can extend calendar time correspondingly. The four-year educational scope therefore does not ensure an unconditional single four-year contract. KI official doctoral vacancy STÖD 2-3548/2026 KI doctoral employment The linked reference guide, updated 12 November 2025, shows an ordinary gross monthly ladder of SEK 32,100 / 32,600 / 34,300 / 34,700, effective from 1 October 2025. The linked collective agreement explicitly covers 1 October 2025–30 September 2026. Its period has elapsed at this review date. These are dated benchmarks, not a confirmed current offer. The medical/dental salary categories do not automatically cover a Biomedical Laboratory Science qualification. Obtain the current agreement, individual classification, starting pay and a payroll illustration. Scholarship net examples in the guide are not this employee's net pay. KI doctoral quick reference dated 12 November 2025 KI local doctoral collective agreement 2025–26 KI explicitly states that doctoral education has no tuition fee regardless of country of origin. This does not settle optional courses, laboratory/project budgets, BioLabX travel or relocation reimbursement. Confirm these items and their payment/approval arrangements in the funded study plan, rather than substituting a taught-master fee policy or the network's total grant. KI doctoral funding and tuition KI's 24 June 2026 BioLabX news names this Maarten project and states that each doctoral student receives a SEK 25,000 resource amount for travel and other expenses. This is a stated resource allocation, not personal salary, an annual payment, the total travel budget or a reimbursement ceiling. Its payment mechanism, allocation between uses, other available funds and individual coverage still require confirmation. KI BioLabX project support

Housing and budget interpretation

KI lists Flemingsberg accommodation from SEK 5,260/month, subject to availability. New KI doctoral students who started within the last six months can apply with an admission decision. Housing is generally limited to one year; up to nine additional months may be requested, without a guarantee. Plan a subsequent housing search. A listed minimum rent is not a personal quotation. KI Housing application and current listed rents KI Housing eligible categories KI Housing rental limits KI's bachelor/master student page publishes a monthly total of SEK 10,520–14,020, but its listed components add to SEK 9,330–12,830, a SEK 1,190 discrepancy. The published total and its listed components are inconsistent. This is a student comparator, not a doctoral employee or family budget. Actual rent, utilities, commuting, insurance, deposit and relocation should be priced independently. Neither total can be subtracted from gross salary to promise savings. KI Stockholm student budget For the doctoral-study permit route, the Migration Agency specifies a 2026 maintenance minimum of SEK 10,656/month and an ordinary adult application fee of SEK 1,500. The maintenance floor is a permit criterion, not a complete living-cost estimate. Non-EU candidates usually need a permit; final full-time admission and financial evidence are required. A hosting agreement may instead lead to the researcher route, so coordinate the individual arrangement with KI. Swedish Migration Agency doctoral permit

Applicant Fit and Preparation

Compulsory conditions and advantageous experience

The professional BLS degree/equivalent restriction is compulsory. General doctoral eligibility separately requires an advanced degree, 240 ECTS including 60 advanced ECTS, or formally assessed equivalent knowledge. That general route does not waive the profession-specific restriction. Laboratory experience, sequencing/bioinformatics, immunological experience and basic programming are advantages; Swedish knowledge is preferred rather than mandatory. English competence must be formally documented. KI official doctoral vacancy STÖD 2-3548/2026 KI doctoral entry requirements and foreign academic documents KI equivalent general eligibility assessment KI follows English 6/Level 2 criteria and does not grant an equivalent-knowledge exception for English. An accepted route is IELTS Academic 6.5 overall, each section at least 5.5. The reference distinguishes TOEFL tests from 21 January 2026 (total 4.5, each section at least 4 on the new scale) from earlier tests (90 total, writing 20). Prior-study routes have specific conditions; a mainland English-medium degree alone should not be assumed sufficient. Submit documents to KI's Varbi process, not a separate central-admissions application. KI doctoral English requirements University Admissions accepted English tests followed by KI KI's foreign-credentials checklist for holders of an advanced degree lists bachelor's and master's degree certificates and complete official transcripts for both stages, with Diploma Supplements if applicable and English evidence. Applicants with ongoing advanced studies provide completed advanced-course records, bachelor's certificate/transcripts (or the alternative permitted by the applicable checklist) and English evidence; an ongoing master's programme outside the EHEA additionally requires its programme syllabus. These documentation routes do not waive the completed professional-degree restriction or general eligibility by the vacancy deadline. Original-language academic documents and required official translations must be supplied; Chinese-language certificates and transcripts normally require Swedish or English translations. A healthcare licence alone cannot replace academic evidence. Incomplete applications are not routinely supplemented after the deadline. Individual professional/academic recognition and immigration decisions remain necessary. KI doctoral entry requirements and foreign academic documents

Suggested evidence, not extra entry requirements

Show a specific contribution to clinical quality, reliable laboratory interpretation or documented quantitative analysis. Explain the question, the data's limitations, personal contribution and what a conclusion does not establish. A focused letter can link that evidence to the clinical-to-analysis interface and BioLabX's educational purpose. Generic interest in infection biology, a purely remote computational expectation, or an assumption that a doctorate automatically grants Swedish clinical practice rights would misread this opportunity. KI official doctoral vacancy STÖD 2-3548/2026 Uppsala coordinator BioLabX grant record

Career relevance

The BioLabX coordinator identifies a need for research-trained laboratory professionals and educators. That supports relevance to clinical research, diagnostics quality and teaching, without establishing a placement rate or guaranteed faculty post. Professional practice or clinical employment may require separate recognition and language qualifications; the doctorate cannot be treated as their substitute. Uppsala coordinator BioLabX grant record

Next Actions and Questions to Verify

Before applying: clarify the professional-degree criterion with the named contact while assembling a complete Varbi application. Include personal letter, CV, degree research/publications if any, evidence of preferred skills, general-eligibility and English documents. Check that requirements are met by 13 November. KI does not provide a preliminary academic-document assessment by ordinary email. Ask about the closing hour and start date rather than assuming a platform default. Recruitment contacts: Research Specialist Maarten van de Klundert (maarten.van.de.klundert@ki.se) and Senior Professor Anders Sönnerborg (anders.sonnerborg@ki.se). Their contact titles do not by themselves allocate formal or daily supervision. KI official doctoral vacancy STÖD 2-3548/2026 KI doctoral entry requirements and foreign academic documents At interview: establish daily and formal supervision, the laboratory/computation balance, already available clinical data and permissions, technical support, and feasible first-year milestones. Ask how cohort limitations and measurement uncertainty will be handled. Agree how BioLabX travel, courses and any teaching fit the research schedule. Before accepting: obtain the current salary and professional classification, initial appointment/renewal arrangements, full-study financing, project/course/travel expense responsibilities beyond the confirmed absence of doctoral tuition, and relocation conditions. Align employment, doctoral registration and the correct residence route. Confirm real housing terms and a plan after temporary KI accommodation.

Evidence and Sources

The saved materials do not establish whether applications are currently being accepted. Varbi is the specified application route, but the post-login upload steps are not established here. The three study discussions are limited to their cited abstracts or selected sections and do not constitute a full methods review.

Project, education and professional context

• KI doctoral education: degree, study funding and no tuition
• Current Medical Science syllabus page
• Medical Science doctoral syllabus linked for post-2018 admissions
• KI official doctoral vacancy STÖD 2-3548/2026
• KI doctoral entry requirements and foreign academic documents
• KI doctoral English requirements
• KI equivalent general eligibility assessment
• KI four BioLabX doctoral projects
• KI Department of Medicine Huddinge
• KI individual study plan
• KI ranking with overall and subject scope
• Uppsala coordinator BioLabX grant record
• MedH doctoral education
• University Admissions accepted English tests followed by KI

Supervision, facilities and recent papers

• Maarten van de Klundert official profile
• Sönnerborg group: clinical, translational and experimental teams
• MedH facilities and organisational change
• 2026 EuResist clinical outcome cohort
• Natural occurrence of drug resistance mutations to the HIV-1 capsid inhibitor lenacapavir
• Linking gut microbiome to HIV-1 reservoir size in people living with HIV

Employment, housing, costs and migration

• KI doctoral employment
• KI Stockholm student budget
• Swedish Migration Agency doctoral permit
• KI doctoral quick reference dated 12 November 2025
• KI local doctoral collective agreement 2025–26
• KI Housing application and current listed rents
• KI Housing eligible categories
• KI Housing rental limits